Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Anhui Provincial Hospital

6 clinical trials · 6 recruiting · OTHER_GOV

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Anhui Provincial Hospital

RECRUITINGEarly Phase 1NCT06462508

Head-to-head Comparison of [18F]F-PSMA-N5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

To prospectively evaluate the radiodrug biodistribution of a novel PET imaging agent \[18F\]F-PSMA-N5 in different organs of prostate cancer patients and its diagnostic efficacy...

Sponsor: Anhui Provincial HospitalEnrolling: 301 location
Prostate CancerPET/CT
RECRUITINGNCT05940415

Conducting Active Surveillance Without Prostate Biopsy for Patients With Low-risk Suspected Prostate Cancer

The goal of this observational study is to evaluate the role of the USTC diagnostic model in risk-adaptive strategies for biopsy decision-making in patients with low-risk...

Sponsor: Anhui Provincial HospitalEnrolling: 2201 location
Prostate Cancer
RECRUITINGPhase 4NCT07150624

The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine

A multicenter, open-label, randomized, controlled study. It is proposed to evaluate the treatment plan of receiving 930mg polyene phosphatidylcholine injection one day before the...

Sponsor: Anhui Provincial HospitalEnrolling: 961 location
Hepatocellular Carcinoma (HCC)Liver Diseases
RECRUITINGNCT07121777

Anti CD19/BCMA CAR Gene Therapy for Autoimmune Diseases

This is an open label, single-site, dose-escalation study in up to 18 participants with treatment of Refractory Autoimmune Diseases. This study aims to evaluate the safety and...

Sponsor: Anhui Provincial HospitalEnrolling: 181 location
Autoimmune Diseases
RECRUITINGNCT07052565

CAR-T Cells Therapy for Patients With Autoimmune Diseases

This is an open label, single-site, dose-escalation study in up to 18 participants with refractory autoimmune diseases. This study aims to evaluate the safety and efficacy of the...

Sponsor: Anhui Provincial HospitalEnrolling: 181 location
Autoimmune Diseases
RECRUITINGEarly Phase 1NCT07085559

Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms...

A Study of Metabolically Armed BCMA CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Plasma Cell Neoplasms.

Sponsor: Anhui Provincial HospitalEnrolling: 361 location
Multiple Myeloma (MM)Plasma Cell Leukemia (PCL)AL Amyloidosis (AL)